The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Postoperative Nausea and Vomiting (PONV)-Global Market Insights and Sales Trends 2024
Synopsis
The global post-operative nausea and vomiting (PONV) market is growing at a significant rate due to bourgeoning incidence rate of post-operative complications and increasing demand for combination therapy, as well as introduction of promising drugs in this segment across the globe.
The global Postoperative Nausea and Vomiting (PONV) market size is expected to reach US$ 2955.4 million by 2029, growing at a CAGR of 6.5% from 2023 to 2029. The market is mainly driven by the significant applications of Postoperative Nausea and Vomiting (PONV) in various end use industries. The expanding demands from the Hospital Pharmacies, Online Pharmacies and Retail Pharmacies,, are propelling Postoperative Nausea and Vomiting (PONV) market. Serotonin Antagonists, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Steroids segment is estimated at % CAGR for the next seven-year period.
Major factors boosting the growth of the post-operative nausea and vomiting market include large number of surgeries performed and rise in the rate of postoperative complications, such as, dizziness, vomiting, and nausea. However, strict regulatory approvals and high health care expenditure are predicted to hamper the growth of the PONV market during the forecast period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Postoperative Nausea and Vomiting (PONV), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Postoperative Nausea and Vomiting (PONV) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Postoperative Nausea and Vomiting (PONV) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Postoperative Nausea and Vomiting (PONV) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Postoperative Nausea and Vomiting (PONV) covered in this report include Acacia Pharma, F. Hoffmann-La Roche, Novartis, Ani Pharmaceuticals, Camurus, Sanofi, Helsinn Holding, Eisai and Merck, etc.
The global Postoperative Nausea and Vomiting (PONV) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Acacia Pharma
F. Hoffmann-La Roche
Novartis
Ani Pharmaceuticals
Camurus
Sanofi
Helsinn Holding
Eisai
Merck
GlaxoSmithKline
Global Postoperative Nausea and Vomiting (PONV) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Postoperative Nausea and Vomiting (PONV) market, Segment by Type:
Serotonin Antagonists
Steroids
Dopamine Antagonists
NK-1 Receptor Antagonists
Non-pharmacologic Treatment
Others
Global Postoperative Nausea and Vomiting (PONV) market, by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Postoperative Nausea and Vomiting (PONV) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global post-operative nausea and vomiting (PONV) market is growing at a significant rate due to bourgeoning incidence rate of post-operative complications and increasing demand for combination therapy, as well as introduction of promising drugs in this segment across the globe.
The global Postoperative Nausea and Vomiting (PONV) market size is expected to reach US$ 2955.4 million by 2029, growing at a CAGR of 6.5% from 2023 to 2029. The market is mainly driven by the significant applications of Postoperative Nausea and Vomiting (PONV) in various end use industries. The expanding demands from the Hospital Pharmacies, Online Pharmacies and Retail Pharmacies,, are propelling Postoperative Nausea and Vomiting (PONV) market. Serotonin Antagonists, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Steroids segment is estimated at % CAGR for the next seven-year period.
Major factors boosting the growth of the post-operative nausea and vomiting market include large number of surgeries performed and rise in the rate of postoperative complications, such as, dizziness, vomiting, and nausea. However, strict regulatory approvals and high health care expenditure are predicted to hamper the growth of the PONV market during the forecast period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Postoperative Nausea and Vomiting (PONV), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Postoperative Nausea and Vomiting (PONV) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Postoperative Nausea and Vomiting (PONV) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Postoperative Nausea and Vomiting (PONV) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Postoperative Nausea and Vomiting (PONV) covered in this report include Acacia Pharma, F. Hoffmann-La Roche, Novartis, Ani Pharmaceuticals, Camurus, Sanofi, Helsinn Holding, Eisai and Merck, etc.
The global Postoperative Nausea and Vomiting (PONV) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Acacia Pharma
F. Hoffmann-La Roche
Novartis
Ani Pharmaceuticals
Camurus
Sanofi
Helsinn Holding
Eisai
Merck
GlaxoSmithKline
Global Postoperative Nausea and Vomiting (PONV) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Postoperative Nausea and Vomiting (PONV) market, Segment by Type:
Serotonin Antagonists
Steroids
Dopamine Antagonists
NK-1 Receptor Antagonists
Non-pharmacologic Treatment
Others
Global Postoperative Nausea and Vomiting (PONV) market, by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Postoperative Nausea and Vomiting (PONV) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Postoperative Nausea and Vomiting (PONV)
1.1 Postoperative Nausea and Vomiting (PONV) Market Overview
1.1.1 Postoperative Nausea and Vomiting (PONV) Product Scope
1.1.2 Postoperative Nausea and Vomiting (PONV) Market Status and Outlook
1.2 Global Postoperative Nausea and Vomiting (PONV) Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Postoperative Nausea and Vomiting (PONV) Market Size by Region (2018-2029)
1.4 Global Postoperative Nausea and Vomiting (PONV) Historic Market Size by Region (2018-2023)
1.5 Global Postoperative Nausea and Vomiting (PONV) Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Postoperative Nausea and Vomiting (PONV) Market Size (2018-2029)
1.6.1 North America Postoperative Nausea and Vomiting (PONV) Market Size (2018-2029)
1.6.2 Europe Postoperative Nausea and Vomiting (PONV) Market Size (2018-2029)
1.6.3 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size (2018-2029)
1.6.4 Latin America Postoperative Nausea and Vomiting (PONV) Market Size (2018-2029)
1.6.5 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size (2018-2029)
2 Postoperative Nausea and Vomiting (PONV) Market by Type
2.1 Introduction
2.1.1 Serotonin Antagonists
2.1.2 Steroids
2.1.3 Dopamine Antagonists
2.1.4 NK-1 Receptor Antagonists
2.1.5 Non-pharmacologic Treatment
2.1.6 Others
2.2 Global Postoperative Nausea and Vomiting (PONV) Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Postoperative Nausea and Vomiting (PONV) Historic Market Size by Type (2018-2023)
2.2.2 Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Postoperative Nausea and Vomiting (PONV) Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Postoperative Nausea and Vomiting (PONV) Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Postoperative Nausea and Vomiting (PONV) Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Postoperative Nausea and Vomiting (PONV) Revenue Breakdown by Type (2018-2029)
3 Postoperative Nausea and Vomiting (PONV) Market Overview by Application
3.1 Introduction
3.1.1 Hospital Pharmacies
3.1.2 Online Pharmacies
3.1.3 Retail Pharmacies
3.2 Global Postoperative Nausea and Vomiting (PONV) Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Postoperative Nausea and Vomiting (PONV) Historic Market Size by Application (2018-2023)
3.2.2 Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Postoperative Nausea and Vomiting (PONV) Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Postoperative Nausea and Vomiting (PONV) Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Postoperative Nausea and Vomiting (PONV) Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Postoperative Nausea and Vomiting (PONV) Revenue Breakdown by Application (2018-2029)
4 Postoperative Nausea and Vomiting (PONV) Competition Analysis by Players
4.1 Global Postoperative Nausea and Vomiting (PONV) Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Postoperative Nausea and Vomiting (PONV) as of 2022)
4.3 Date of Key Players Enter into Postoperative Nausea and Vomiting (PONV) Market
4.4 Global Top Players Postoperative Nausea and Vomiting (PONV) Headquarters and Area Served
4.5 Key Players Postoperative Nausea and Vomiting (PONV) Product Solution and Service
4.6 Competitive Status
4.6.1 Postoperative Nausea and Vomiting (PONV) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Acacia Pharma
5.1.1 Acacia Pharma Profile
5.1.2 Acacia Pharma Main Business
5.1.3 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Products, Services and Solutions
5.1.4 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Revenue (US$ Million) & (2018-2023)
5.1.5 Acacia Pharma Recent Developments
5.2 F. Hoffmann-La Roche
5.2.1 F. Hoffmann-La Roche Profile
5.2.2 F. Hoffmann-La Roche Main Business
5.2.3 F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Products, Services and Solutions
5.2.4 F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Revenue (US$ Million) & (2018-2023)
5.2.5 F. Hoffmann-La Roche Recent Developments
5.3 Novartis
5.3.1 Novartis Profile
5.3.2 Novartis Main Business
5.3.3 Novartis Postoperative Nausea and Vomiting (PONV) Products, Services and Solutions
5.3.4 Novartis Postoperative Nausea and Vomiting (PONV) Revenue (US$ Million) & (2018-2023)
5.3.5 Ani Pharmaceuticals Recent Developments
5.4 Ani Pharmaceuticals
5.4.1 Ani Pharmaceuticals Profile
5.4.2 Ani Pharmaceuticals Main Business
5.4.3 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Products, Services and Solutions
5.4.4 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Revenue (US$ Million) & (2018-2023)
5.4.5 Ani Pharmaceuticals Recent Developments
5.5 Camurus
5.5.1 Camurus Profile
5.5.2 Camurus Main Business
5.5.3 Camurus Postoperative Nausea and Vomiting (PONV) Products, Services and Solutions
5.5.4 Camurus Postoperative Nausea and Vomiting (PONV) Revenue (US$ Million) & (2018-2023)
5.5.5 Camurus Recent Developments
5.6 Sanofi
5.6.1 Sanofi Profile
5.6.2 Sanofi Main Business
5.6.3 Sanofi Postoperative Nausea and Vomiting (PONV) Products, Services and Solutions
5.6.4 Sanofi Postoperative Nausea and Vomiting (PONV) Revenue (US$ Million) & (2018-2023)
5.6.5 Sanofi Recent Developments
5.7 Helsinn Holding
5.7.1 Helsinn Holding Profile
5.7.2 Helsinn Holding Main Business
5.7.3 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Products, Services and Solutions
5.7.4 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Revenue (US$ Million) & (2018-2023)
5.7.5 Helsinn Holding Recent Developments
5.8 Eisai
5.8.1 Eisai Profile
5.8.2 Eisai Main Business
5.8.3 Eisai Postoperative Nausea and Vomiting (PONV) Products, Services and Solutions
5.8.4 Eisai Postoperative Nausea and Vomiting (PONV) Revenue (US$ Million) & (2018-2023)
5.8.5 Eisai Recent Developments
5.9 Merck
5.9.1 Merck Profile
5.9.2 Merck Main Business
5.9.3 Merck Postoperative Nausea and Vomiting (PONV) Products, Services and Solutions
5.9.4 Merck Postoperative Nausea and Vomiting (PONV) Revenue (US$ Million) & (2018-2023)
5.9.5 Merck Recent Developments
5.10 GlaxoSmithKline
5.10.1 GlaxoSmithKline Profile
5.10.2 GlaxoSmithKline Main Business
5.10.3 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Products, Services and Solutions
5.10.4 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Revenue (US$ Million) & (2018-2023)
5.10.5 GlaxoSmithKline Recent Developments
6 North America
6.1 North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Postoperative Nausea and Vomiting (PONV) Market Dynamics
11.1 Postoperative Nausea and Vomiting (PONV) Industry Trends
11.2 Postoperative Nausea and Vomiting (PONV) Market Drivers
11.3 Postoperative Nausea and Vomiting (PONV) Market Challenges
11.4 Postoperative Nausea and Vomiting (PONV) Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
